Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 24Colorectal Neoplasms 19Rectal Neoplasms 11Stomach Neoplasms 8Colonic Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Carcinoma, Hepatocellular 7Neoplasm Metastasis 6Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Liver Neoplasms 5Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Osteosarcoma 4Esophageal Neoplasms 4Cholangiocarcinoma 4Peritoneal Neoplasms 3Ovarian Neoplasms 3Neuroblastoma 3Multiple Myeloma 3Lung Neoplasms 3Locally Advanced Rectal Cancer 3Kidney Neoplasms 3Inflammatory Breast Neoplasms 3Turcot syndrome 2Sarcoma 2Pancreatic Neoplasms 2Nasopharyngeal Carcinoma 2Head and Neck Neoplasms 2Glioblastoma 2

Interventions

Trastuzumab 2Ivabradine 2Exercise 2Echocardiography 2Bisoprolol 2salicylhydroxamic acid 1sacubitril and valsartan sodium hydrate drug combination 1mitoquinone 1epicatechin gallate 1dapagliflozin 1candesartan 1Trimetazidine 1Therapeutics 1Surveys and Questionnaires 1Spironolactone 1Silymarin 1Secondary Prevention 1Restraint, Physical 1Ramipril 1Radiotherapy 1Perindopril 1Neoadjuvant Therapy 1Nebivolol 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Fluorouracil 1Epirubicin 1Docetaxel 1Cyclophosphamide 1Cisplatin 1Carvedilol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Cardiotoxicity × Neoadjuvant Therapy × Clear all
NCT01093235 2010-03-25

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
800 enrolled
Breast

Breast Neoplasms, Postoperative Complications, Breast Neoplasms, Male, Inflammatory Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡